Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/03/2010US20100137347 5-[3-((1S,2R)-2-{4-[1-(4-Methoxy-benzyloxy)-hexyl]-phenyl}-3-methylene-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester; glaucoma, inflammatory bowel disease, the stimulation of hair growth, and the stimulation of the conversion of vellus hair to terminal hair
06/03/2010US20100137346 Desferrithiocin analogue actinide decorporation agents
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137344 Induction of analgesia in neuropathic pain
06/03/2010US20100137343 Substituted quinazolines
06/03/2010US20100137342 Methods for treating vascular disruption disorders
06/03/2010US20100137341 Dna polymerase inhibitors composition and methods
06/03/2010US20100137340 Fused pyrimidinone compounds as mglur ligands
06/03/2010US20100137339 Amorphous form of n--n-methyl-acetamide
06/03/2010US20100137338 INHIBITORS OF Akt ACTIVITY
06/03/2010US20100137336 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/03/2010US20100137335 Metabolites of (thio) carbamoyl-cyclohexane derivatives
06/03/2010US20100137334 Piperidine and Piperazine Derivatives
06/03/2010US20100137333 Antifungal composition and methods for using
06/03/2010US20100137332 Piperazine modulators of nk-1 receptors
06/03/2010US20100137331 Quinolines Useful as Modulators of ION Channels
06/03/2010US20100137330 Use
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137328 Tricyclic anilide heterocyclic cgrp receptor antagonists
06/03/2010US20100137327 Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators
06/03/2010US20100137326 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/03/2010US20100137325 Biphenyl compounds useful as muscarinic receptor antagonists
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137323 Benzo-fused compounds for use in treating metabolic disorders
06/03/2010US20100137322 Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
06/03/2010US20100137321 IMIDAZO[1,2-a]AZINES AND THEIR USE AS PHARMACEUTICALS
06/03/2010US20100137320 Gamma secretase modulators
06/03/2010US20100137319 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
06/03/2010US20100137318 Bicyclic heterocyclic compound
06/03/2010US20100137317 1,2-Disubstituted Heterocyclic Compounds
06/03/2010US20100137316 Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof
06/03/2010US20100137315 Sphingosine Kinase Inhibitors and Methods of Their Use
06/03/2010US20100137313 Heterocyclic derivatives and methods of use thereof
06/03/2010US20100137312 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
06/03/2010US20100137311 Substituted pyrimidine derivatives
06/03/2010US20100137310 Renin inhibitors
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137307 Novel 1,2,3,4,-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced terein and has glucocorticoid receptor-binding activity
06/03/2010US20100137306 Heterocyclic trpv1 receptor ligands
06/03/2010US20100137305 Aminopyrimidines useful as kinase inhibitors
06/03/2010US20100137304 Novel crystalline forms of the anti-cancer compound zd1839
06/03/2010US20100137303 New compound 255
06/03/2010US20100137302 Fused Thiazole Derivatives as Kinase Inhibitors
06/03/2010US20100137301 Substituted Indolealkanoic Acids
06/03/2010US20100137300 Indolizine Acetic Acid Derivatives as CRTH2 Antagonists
06/03/2010US20100137299 Spiro-oxindole compounds and their use as therapeutic agents
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137297 Spiroindalones
06/03/2010US20100137296 N-phenyl anthranilic acid derivatives and uses thereof
06/03/2010US20100137295 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
06/03/2010US20100137293 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
06/03/2010US20100137292 Pharmaceutical formulations of meloxicam
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137290 Oxazolidinone antibiotic derivatives
06/03/2010US20100137289 Methods and Compositions for Ameliorating Thiazide Induced Hyperlipidemia
06/03/2010US20100137288 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
06/03/2010US20100137287 Aryl-and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
06/03/2010US20100137286 Arylcyclohexylethers of dihydrotetraazabenzoazulenes
06/03/2010US20100137285 Small molecule modulators of cytokine activity
06/03/2010US20100137284 Compositions for the Treatment and Prevention of Heart Disease and Methods of Using Same
06/03/2010US20100137283 Inhibitors of the hiv integrase enzyme
06/03/2010US20100137282 Tricyclic nitrogen containing compounds as antibacterial agents
06/03/2010US20100137281 Heterocyclic compound and use thereof
06/03/2010US20100137280 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
06/03/2010US20100137279 4-methylpyridopyrimidinone compounds
06/03/2010US20100137278 Pyrazine compounds as phosphodiesterase 10 inhibitors
06/03/2010US20100137277 Pyridine compounds and their use as p2y12 antagonists
06/03/2010US20100137276 Compounds which potentiate ampa receptor and uses thereof in medicine
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/03/2010US20100137273 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions
06/03/2010US20100137272 Zinc Salt Of Isothiazolone Compound, Method For Reducing Irritation Caused By Isothiazolone Compound, Antibacterial and Antifungal Method Using Zinc Salt of Isothiazolone Compound, and Antibacterial and Antifungal Composition
06/03/2010US20100137271 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
06/03/2010US20100137270 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/03/2010US20100137269 Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens: Synehesis, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
06/03/2010US20100137268 Phthalazinone modulators of h1 receptors and/or ltc4 receptors
06/03/2010US20100137267 Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue
06/03/2010US20100137266 Treatment of insulin resistance and disorders associated therewith
06/03/2010US20100137265 Treatment of conditions relating to hormone deficiencies by administration of progestins
06/03/2010US20100137264 Progestational 3-(6,6-ethylene-17b-hydroxy-3-oxo-17a-pregna-4-ene-17a-yl)propionic acid g-lactones
06/03/2010US20100137263 Assay for the detection of biomarkers associated with pregnancy related conditions
06/03/2010US20100137262 Low Calcemic, Highly Antiproliferative, Analogs of Calcitriol
06/03/2010US20100137261 Method for treating aortic stenosis with non-antibacterial tetracycline formulations
06/03/2010US20100137260 compound for inhibiting trpv3 function and use thereof
06/03/2010US20100137259 Compound for inhibiting trpa1 function and use thereof
06/03/2010US20100137258 Thiophosphi(o)nic acid derivatives and their therapeutical applications
06/03/2010US20100137257 Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
06/03/2010US20100137256 Device and Method for Treating Human Body
06/03/2010US20100137255 Creatine phosphate analog prodrugs, compositions and uses thereof
06/03/2010US20100137254 Phosphoramidate alkylator prodrugs
06/03/2010US20100137253 Therapeutic compound and treatments
06/03/2010US20100137252 Ophthalmic composition
06/03/2010US20100137251 Functional Role for Cannabinoids in Autonomic Stability During Sleep
06/03/2010US20100137250 Naphthylacetic acids
06/03/2010US20100137248 Boron-containing compounds, uses and preparation thereof
06/03/2010US20100137247 Anti-inflammatory compositions and methods
06/03/2010US20100137246 Anti-inflammatory compositions and methods
06/03/2010US20100137244 Preparation and utility of hmg-coa reductase inhibitors
06/03/2010US20100137243 Oxazolidinone And/Or Isoxazoline As Antibacterial Agents
06/03/2010US20100137242 Paromomycin supplemented feedingstuffs for poultry species and use thereof for prophylaxis of histomoniasis, reduction of the horizontal spreading of histomoniasis, and for improved weight gain and feed conversion
1 ... 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 ... 7860